WEST PALM BEACH, FL--(Marketwire - June 17, 2008) - Advatech Corporation (PINKSHEETS: ADVA) today announced that it has entered into an Agreement with the Kennedy Krieger Institute of Johns Hopkins University. Pursuant to the Agreement, the Kennedy Krieger Institute has commenced research utilizing Advatech's patented Field Therapy Accelerator ("FTA") device and related technologies. Initial trials will focus on "in-vitro" studies of the enhancement of stem cell cultures as well as the potential development of treatment for spinal cord injuries. Future "in-vivo" studies of stem cell implantation are also intended. The Kennedy Krieger Institute, located in Baltimore, MD, is an internationally recognized research institute renowned for its work in pioneering new interventions and diagnosis and understanding disorders and injuries of the brain and spinal cord.
